| 000 | 01844 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250518080426.0 | ||
| 264 | 0 | _c20210505 | |
| 008 | 202105s 0 0 eng d | ||
| 022 | _a1536-3694 | ||
| 024 | 7 |
_a10.1097/FTD.0000000000000721 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYamazaki, Shingo | |
| 245 | 0 | 0 |
_aPopulation Pharmacokinetics of Vancomycin Under Continuous Renal Replacement Therapy Using a Polymethylmethacrylate Hemofilter. _h[electronic resource] |
| 260 |
_bTherapeutic drug monitoring _c06 2020 |
||
| 300 |
_a452-459 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAPACHE |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 |
_aContinuous Renal Replacement Therapy _xmethods |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemodiafiltration _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOrgan Dysfunction Scores |
| 650 | 0 | 4 |
_aPolymethyl Methacrylate _xchemistry |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aVancomycin _xpharmacokinetics |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aTatebe, Mizuki | |
| 700 | 1 | _aFujiyoshi, Masachika | |
| 700 | 1 | _aHattori, Noriyuki | |
| 700 | 1 | _aSuzuki, Tatsuya | |
| 700 | 1 | _aTakatsuka, Hirokazu | |
| 700 | 1 | _aUchida, Masashi | |
| 700 | 1 | _aSuzuki, Takaaki | |
| 700 | 1 | _aIshii, Itsuko | |
| 773 | 0 |
_tTherapeutic drug monitoring _gvol. 42 _gno. 3 _gp. 452-459 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FTD.0000000000000721 _zAvailable from publisher's website |
| 999 |
_c30495589 _d30495589 |
||